![Anthony Smithyman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony Smithyman
Algemeen Directeur bij Special Phage Holdings Pty Ltd.
Actieve functies van Anthony Smithyman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Special Phage Holdings Pty Ltd.
![]() Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Special Phage Holdings Pty Ltd. operates as a holding Australian company with interests in phage therapy. The company is based in Neutral Bay, Australia. The company was founded by Anthony Smithyman. Anthony Smithyman has been the CEO since incorporation. Special Phage Holdings was acquired by AmpliPhi Australia Pty Ltd. on November 13, 2012 for $6.77 million. | Algemeen Directeur | 23-01-2014 | - |
Oprichter | 23-01-2014 | - | |
Cellabs Pty Ltd.
![]() Cellabs Pty Ltd. Medical/Nursing ServicesHealth Services Cellabs Pty Ltd. is a boutique diagnostics company based in Sydney that specializes in designing, developing, and manufacturing immunodiagnostic kits for tropical and infectious diseases. The Australian company's focus is on providing accurate and reliable diagnostic solutions to healthcare professionals and patients. The CEO of the private company is Anthony Smithyman. | Algemeen Directeur | - | - |
Loopbaan van Anthony Smithyman
Eerdere bekende functies van Anthony Smithyman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 01-11-2012 | 16-04-2015 |
Opleiding van Anthony Smithyman
University of St. Andrews | Undergraduate Degree |
University of Glasgow | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 3 |
Australië | 3 |
Verenigde Staten | 2 |
Operationeel
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Special Phage Holdings Pty Ltd.
![]() Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Special Phage Holdings Pty Ltd. operates as a holding Australian company with interests in phage therapy. The company is based in Neutral Bay, Australia. The company was founded by Anthony Smithyman. Anthony Smithyman has been the CEO since incorporation. Special Phage Holdings was acquired by AmpliPhi Australia Pty Ltd. on November 13, 2012 for $6.77 million. | Health Technology |
Cellabs Pty Ltd.
![]() Cellabs Pty Ltd. Medical/Nursing ServicesHealth Services Cellabs Pty Ltd. is a boutique diagnostics company based in Sydney that specializes in designing, developing, and manufacturing immunodiagnostic kits for tropical and infectious diseases. The Australian company's focus is on providing accurate and reliable diagnostic solutions to healthcare professionals and patients. The CEO of the private company is Anthony Smithyman. | Health Services |
- Beurs
- Insiders
- Anthony Smithyman
- Ervaring